Catalent, Inc. to Present at March Investor Conferences
09 März 2023 - 10:31PM
Business Wire
Catalent, Inc. (NYSE: CTLT), the leader in enabling the
development and supply of better treatments for patients worldwide,
today announced that members of its executive leadership team will
participate at two upcoming investor conferences.
On March 14, 2023 at 10:45 a.m. ET, the Company will present at
the Barclays Global Healthcare Conference.
On March 21, 2023, at 12:00 p.m. ET, the Company will present at
the KeyBanc Life Sciences & MedTech Investor Forum.
A live webcast of the presentation will be accessible at
http://investor.catalent.com and will be available for replay
following the event.
About Catalent Catalent, Inc. (NYSE: CTLT), an S&P
500® company, is the global leader in enabling pharma, biotech, and
consumer health partners to optimize product development, launch,
and full life-cycle supply for patients around the world. With
broad and deep scale and expertise in development sciences,
delivery technologies, and multi-modality manufacturing, Catalent
is a preferred industry partner for personalized medicines,
consumer health brand extensions, and blockbuster drugs. Catalent
helps accelerate over 1,000 partner programs and launch over 150
new products every year. Its flexible manufacturing platforms at
over 50 global sites supply around 80 billion doses of nearly 8,000
products annually. Catalent’s expert workforce of approximately
18,000 includes more than 3,000 scientists and technicians.
Headquartered in Somerset, New Jersey, the company generated nearly
$5 billion in revenue in its 2022 fiscal year. For more information
www.catalent.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230309005189/en/
Investor Contact: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024